Arbeitspapier
Drug Pricing Decisions and Insurance Coverage: Evidence from Medicare Part D
We examine whether the pricing of brand drugs, relative to estimates of their clinical value, is related to the way insurers cover those products in Medicare Part D. The net prices of drugs in our sample vary significantly relative to value-based prices from the Institute for Clinical and Economic Review (ICER), indicating meaningfully different pricing strategies. Coverage decisions, formulary placement, and use of utilization management are clearly responsive to first-order differences in costs of products generally. However, among the subset of relatively high-cost products with value-based price estimates, we observe little relationship between pricing strategies and extensive margin coverage decisions. Plans that cover larger shares of lower-value products tend to have permissive coverage policies and higher resulting premiums. Among potential explanations, we highlight institutional features that may help explain these results and propose an empirical test surrounding upcoming policy changes due to the Inflation Reduction Act.
- Sprache
-
Englisch
- Erschienen in
-
Series: AEI Economics Working Paper ; No. 2023-10
- Klassifikation
-
Wirtschaft
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Ippolito, Benedic N.
Levy, Joseph F.
- Ereignis
-
Veröffentlichung
- (wer)
-
American Enterprise Institute (AEI)
- (wo)
-
Washington, DC
- (wann)
-
2023
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:46 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Arbeitspapier
Beteiligte
- Ippolito, Benedic N.
- Levy, Joseph F.
- American Enterprise Institute (AEI)
Entstanden
- 2023
Ähnliche Objekte (12)
The effect of Medicare eligibility on spousal insurance coverage
Is expanding Medicare coverage cost-effective?
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Ensuring access to affordable drug coverage in Medicare
Pricing : a guide to pricing decisions
Risk attitudes and Medicare Part D enrollment decisions
Risk attitudes and Medicare Part D enrollment decisions
Low-Probability Insurance Decisions
Nonlinear pricing, market coverage, and competition
Deposit insurance: Pricing and incentives
An empirical model of medicare costs: The role of health insurance, employment, and delays in medicare enrollment
Minimum coverage regulation in insurance markets
The effect of Medicare eligibility on spousal insurance coverage
Is expanding Medicare coverage cost-effective?
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Ensuring access to affordable drug coverage in Medicare
Pricing : a guide to pricing decisions
Risk attitudes and Medicare Part D enrollment decisions
Risk attitudes and Medicare Part D enrollment decisions
Low-Probability Insurance Decisions
Nonlinear pricing, market coverage, and competition
Deposit insurance: Pricing and incentives
An empirical model of medicare costs: The role of health insurance, employment, and delays in medicare enrollment
Minimum coverage regulation in insurance markets
The effect of Medicare eligibility on spousal insurance coverage
Is expanding Medicare coverage cost-effective?
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Ensuring access to affordable drug coverage in Medicare
Pricing : a guide to pricing decisions
Risk attitudes and Medicare Part D enrollment decisions
Risk attitudes and Medicare Part D enrollment decisions
Low-Probability Insurance Decisions
Nonlinear pricing, market coverage, and competition
Deposit insurance: Pricing and incentives
An empirical model of medicare costs: The role of health insurance, employment, and delays in medicare enrollment